# A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants

> **NCT05154968** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 44 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Sodium chloride
- **DRUG:** Citrate buffer
- **DRUG:** Mannitol
- **DEVICE:** Prefilled Autoinjector

## Key facts

- **NCT ID:** NCT05154968
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-24
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2022-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05154968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05154968, "A Study of Two Formulations (Both Refrigerated and Room Temperature) Using an Autoinjector Device in Healthy Participants". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05154968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*